Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
3,233 results in Europe PMC
PubMed plus preprints and full-text open access papers. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Circular RNAs in amyotrophic lateral sclerosis.
Ataei R, Amini J, Sanadgol N, Simon AF, Duennwald ML. · Neurobiol Dis · 2026 · cited 0 timessystematic review, review
- DNL343 and Disease Progression in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Paganoni S, Chibnik LB, Quintana M, Macklin EA, Detry MA, Vestrucci M, Paulon G, McGlothlin A, Wang J, Walk D, Elman L, Chase M, Heyd L, Harkey B, Sherman AV, Shefner J, Berry JD, Scirocco E, Giacomelli E, Yu H, Kittle G, Hall M, Ho D, Jawdat O, Ladha S, Locatelli E, Rivner M, Felice K, Katz J, Ajroud-Driss S, Fee D, Miller T, Rosow L, Quick A, Heitzman D, Foster LA, Maragakis NJ, Goutman SA, Rosenfeld J, Benatar M, Swenson A, Connors RD, Shroff S, Bedlack R, McIlduff CE, Chen IA, Fernandes JAM, Walsh A, Peltier A, Ilieva H, Diaz F, Kushlaf H, Beydoun SR, Myers B, Arcila-Londono X, Heiman-Patterson T, Elliott M, Whitesell J, Al-Lahham T, Elliott M, Olney N, Baer M, Jackson C, Young E, Caress J, Weiss MD, Kuenzler R, Nayar S, Kasarskis EJ, Simmons Z, Gibson S, Owegi MA, Goyal NA, Wymer JP, Gwathmey KG, Erickson A, Gursoy N, Alameda G, Bodkin C, Wu A, Martinez-Thompson J, Twydell PT, Andrews J, Bayat E, Rezania K, Usman U, McCluskey L, Kovvuru S, Jennings D, Garza-Meilandt A, Maciuca R, Cohen IV, Tamuly D, Eren E, Cudkowicz ME, Babu S, HEALEY ALS Platform Trial Study Group. · JAMA Netw Open · 2026 · cited 0 timesOpen accessclinical trial, phase iii, clinical trial, phase ii
- A systematic review and meta-analysis of OCT-based ophthalmic changes in amyotrophic lateral sclerosis.
Ahsan A, Ou JC, Majumder P, Chiang YH, Huang JK, Huang CS. · J Neuroimmunol · 2026 · cited 0 timesmeta-analysis, systematic review
- Applications of electromyography in Amyotrophic Lateral Sclerosis: A systematic review.
Fernandes APM, Bertucci Borges LH, Holanda LJ, Bezerra BHES, Lopes ACSM, Silva MCFD, Valentim RAM, Bougrain L, Vasiljevic GAM, Rodrigues Lindquist AR. · PLoS One · 2026 · cited 0 timesOpen accesssystematic review
- Occupational exposure to pesticides increases the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis.
Labrèche F, Prud'homme P, Gagnon M, Dupré N, Gravel S. · Occup Environ Med · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Safety and efficacy of daily oral edaravone (FNP122) in patients with amyotrophic lateral sclerosis (ADORE): a multicentre, double-blind, phase 3, randomised controlled trial.
van Eijk RPA, Povedano M, Van Damme P, Chiò A, McDermott CJ, Al-Chalabi A, Hardiman O, Varona C, Tarragó C, Nadal T, Albareda N, van den Berg LH, ADORE Study Group. · Lancet Neurol · 2026 · cited 0 timesclinical trial, phase iii, multicenter study
- Exploring Genetic Therapies Targeting Amyotrophic Lateral Sclerosis in Animal Models: A Systematic Review and Meta-Analysis.
Wedgwood HE, Tuxworth RI, Ahmed Z. · J Gene Med · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Prevalence of and associated factors for sleep disorders in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis.
Xie G, Guo Y, Wang Z. · Front Neurol · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Oligonucleotide-siRNA conjugate for SOD1 amyotrophic lateral sclerosis: a phase 1 trial.
Chen W, Jiang L, Duan C, Kang M, Ye J, Wang L, Pan Y, Qu H, Liao X, Zhou X, Li Y, Gan Z, Chen J, Schacht I, Place RF, Li LC, Wang Y. · Nat Med · 2026 · cited 4 timesOpen accessclinical trial, phase i
- Noninvasive assessment of cardiovascular autonomic reflexes in amyotrophic lateral sclerosis: a systematic review.
Rozman SI, Hamzaid NA, Lim E, Hamzah N. · Amyotroph Lateral Scler Frontotemporal Degener · 2026 · cited 0 timessystematic review
- Safety and Efficacy of PrimeC in Amyotrophic Lateral Sclerosis: The PARADIGM Randomized Clinical Trial.
Cudkowicz M, Drory VE, Chio A, Lunetta C, Shoesmith C, van Eijk RPA, Salomon-Zimri S, Shtossel D, Kerem N, Shapira G, Shomron N, Russek-Blum N, Tracik F, Rosenfeld J, Shefner J. · JAMA Neurol · 2026 · cited 5 timesOpen accessclinical trial, phase ii, multicenter study
- Effects of respiratory muscle training on respiratory function in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis.
Lei Y, Huang J, Li M, Zhang Y, Ye Z, He X, Tang Z, Wei J. · J Neurol · 2026 · cited 1 timesmeta-analysis, systematic review
- Head injuries as a risk factor for amyotrophic lateral sclerosis: A systematic review and meta-analysis.
Toubasi AA, Al-Sayegh TN. · Clin Neurol Neurosurg · 2026 · cited 0 timesmeta-analysis, systematic review
- Huoling Shengji granule in amyotrophic lateral sclerosis: A multicenter, randomized, double-blind, riluzole-controlled trial.
Liu X, Fu W, Cui X, Feng Y, Wen B, Shan L, Xu X, Yang J, Zhang J, He L, Zang Y, Zhao S, Yao X, Liu Y, Ma M, Du B, Dang J, Zou Z, Feng H, Lu Z, Zhang Y, Wu Z, Shang H, Yin P, Fan D. · Neurotherapeutics · 2026 · cited 1 timesOpen accessclinical trial, phase ii, multicenter study
- Extracellular vesicles as a liquid biopsy for amyotrophic lateral sclerosis: a systematic review and meta-analysis.
Bolsinger MM, Vivek N, Singh J, Challa A, Zhu A, Rothell T, Wang S, Zhang T, Zhu S, Robbins N, Fenwick L, Ruttenberg G, Bogoniewski A, Taha HB. · J Transl Med · 2026 · cited 2 timesOpen accessmeta-analysis, research support, non-u.s. gov't
- The Emotional Experiences of Healthcare Professionals Working in Amyotrophic Lateral Sclerosis: A Systematic Review.
Chan Y, Creer S, Mere J, Griffiths AW, Wright C, Hobson EV, McDermott CJ, Mayberry EJ. · Muscle Nerve · 2026 · cited 1 timesOpen accesssystematic review, review-article
- Selected traditional Chinese medicines for treating amyotrophic lateral sclerosis: a Bayesian network meta-analysis based on randomised controlled trials.
Shen C, Wu XT, Yin H, Zuo JL, Zhang CH, Cao F, Zhang Y, Tian ZY, Robinson N, Liu JP. · Front Pharmacol · 2026 · cited 0 timesOpen accesssystematic review, systematic-review
- Long-Term Tofersen in SOD1 Amyotrophic Lateral Sclerosis.
Miller TM, Cudkowicz ME, Shaw PJ, Genge A, Sobue G, Bucelli RC, Chiò A, Van Damme P, Ludolph AC, Glass JD, Andrews JA, Babu S, Benatar M, McDermott CJ, Salachas F, Bruneteau G, Al-Chalabi A, Amorin M, Nestorov I, Graham D, Lin L, Sun P, McNeill M, Malek S, Inra J, Garafalo S, Fradette S, VALOR and OLE Working Group. · JAMA Neurol · 2026 · cited 31 timesOpen accessclinical trial, phase iii, multicenter study
- Safety profile of tofersen in amyotrophic lateral sclerosis: a systematic review and meta-analysis.
Tarazona-Santabalbina FJ, Belenguer-Varea A, Borrás-Blasco J, García-Tercero E, Martin ML, Prior NP, Mariscal G, Valcuende-Rosique A. · Neurol Sci · 2026 · cited 0 timesmeta-analysis, systematic review
- Beyond outcomes: patients' lived experience of exoskeleton-assisted gait training in amyotrophic lateral sclerosis.
Trad G, Lenglet T, Querin G, Blancho S, Marchand-Pauvert V, Hogrel JY, Pradat PF. · Amyotroph Lateral Scler Frontotemporal Degener · 2026 · cited 0 timesclinical trial
- Immune effects of faecal microbiota transplantation in amyotrophic lateral sclerosis: a pilot multicentre, randomised, masked, sham-controlled, proof-of concept trial.
Zucchi E, Niccolai E, De Maio F, Cuoghi Costantini R, Quaranta G, Guarnaccia A, Bibbò S, Martinelli I, Gianferrari G, Simonini C, Nannini G, Lulli M, Baldi S, Bartolucci G, Vicini R, Capasso M, Bisogni G, Conte A, Brunori P, Cammarota G, Paganoni S, D'Amico R, Amedei A, Masucci L, Mandrioli J, FETR-ALS Study Group. · EBioMedicine · 2026 · cited 0 timesOpen accessmulticenter study, randomized controlled trial
- Subjective sleep quality in amyotrophic lateral sclerosis: a systematic review and meta-analysis.
Oh J, Oh SI. · Amyotroph Lateral Scler Frontotemporal Degener · 2026 · cited 3 timesmeta-analysis, research support, non-u.s. gov't
- The effect of statins on the survival of patients with amyotrophic lateral sclerosis: a meta-analysis.
Zhou H, Meng T, Liang D, Wang Y. · Front Neurol · 2026 · cited 0 timesOpen accesssystematic review, systematic-review
- Safety, tolerability, and efficacy of RIPK1 inhibitor, SAR443820, in amyotrophic lateral sclerosis (HIMALAYA): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Cudkowicz ME, Shefner J, van den Berg LH, Chio A, Fan D, Großkreutz J, Lunetta C, Tsai RM, Li Y, Wallstroem E, Xiong L, Chen Y, Atassi N, HIMALAYA Phase 2 Study Group. · Lancet Neurol · 2026 · cited 0 timesclinical trial, phase ii, multicenter study
- Accuracy of muscle ultrasonography in detecting fasciculations for the diagnosis of amyotrophic lateral sclerosis: a systematic review and meta-analysis.
Tang Z, Lei Y, Huang J, He R, Wu Y, Li M, Ye Z, He X, Heng H, Zha Y, Wei J. · J Neurol · 2026 · cited 1 timesmeta-analysis, systematic review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.